InvestBio Ventures-The Vaccine Company

The Vaccine Company (TVC) is a biotechnology firm founded by InvestBio to develop a rapid-response vaccine platform for infectious diseases. The company utilizes a 'plug-and-play' recombinant protein technology designed to accelerate the development and manufacturing of vaccines against emerging viral threats. TVC's pipeline includes candidates for COVID-19 and a universal influenza vaccine, aiming for high stability and scalability. Based in New York, the company leverages the strategic and financial expertise of its parent investment firm to advance its programs through early-stage development. TVC focuses on addressing global health challenges by providing versatile and cost-effective immunization solutions. The company's business model emphasizes internal R&D and potential strategic partnerships for clinical advancement.